The genes coding resistance to the second-line TB drugs, such as moxifloxacin, bedaquiline, ethionamide and kanamycin/amikacin (gyrB, atpE, ethR and eis), were the most frequently detected from both influent and effluent samples (Table 3). The gene discussed is ATP5F1E; the disease is tuberculosis.